TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29304848

Group type: EXPERIMENTAL
Intervention: Intravenous ferric carboxymaltose (FCM)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Iron sucrose (IS)
Number of subjects: 200
Study: 27142448

Group type: EXPERIMENTAL
Intervention: Green tea (2 g/day, containing 220.2 mg of catechins)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo (0.0 mg of catechins)
Number of subjects: 33
Study: 24522178

Group type: EXPERIMENTAL
Intervention: efavirenz 400 mg
Number of subjects: 630

Group type: COMPARATOR
Intervention: efavirenz 600 mg
Number of subjects: 630
Study: 22018092

Group type: EXPERIMENTAL
Intervention: Exercise intervention (1.65 MJ expended on day 1)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (resting conditions)
Number of subjects: 14
Study: 21313892

Group type: EXPERIMENTAL
Intervention: Oral clonidine (0.2 mg)
Number of subjects: 274

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 274
Study: 17468586

Group type: EXPERIMENTAL
Intervention: Hypoxia group (11% O2 on days 1-7 and 10% O2 on days 8-15)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (compressed air)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Hypoxia group
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study: 14965404

Group type: EXPERIMENTAL
Intervention: Outreach visits to promote national guidelines on acute low back pain, access to fast-track physiotherapy, and a triage service for patients with persistent symptoms.
Number of subjects: 2187

Group type: COMPARATOR
Intervention: Control group (no outreach visits, standard care).
Number of subjects: 2187
Study: 11823923

Group type: EXPERIMENTAL
Intervention: Acetylcholinesterase Inhibitors (AChEI)
Number of subjects: 0
Study: 9817530

Group type: EXPERIMENTAL
Intervention: Sequential therapy with zidovudine, didanosine and zalcitabine
Number of subjects: 53

Group type: COMPARATOR
Intervention: Monotherapy with zidovudine
Number of subjects: 53
Study: 7711990

Group type: EXPERIMENTAL
Intervention: Epidural meperidine 1 mg kg‐1
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Epidural pentazocine 0.3 mg kg‐1
Number of subjects: 20
Study: 2674395

Group type: EXPERIMENTAL
Intervention: Antimicrobial agent delivered by an oral irrigating device
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control (half mouth dental prophylaxis)
Number of subjects: 66
Study: 386307

Group type: EXPERIMENTAL
Intervention: Bromocriptine
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 31259755

Group type: EXPERIMENTAL
Intervention: 1.5% lidocaine
Number of subjects: 48

Group type: COMPARATOR
Intervention: 0.5% levobupivacaine
Number of subjects: 48
Study: 31106377

Group type: EXPERIMENTAL
Intervention: Rifampicin plus β‐lactam antibiotics
Number of subjects: 41

Group type: COMPARATOR
Intervention: β‐lactam antibiotics only
Number of subjects: 41
Study: 27614097

Group type: EXPERIMENTAL
Intervention: Very Low Nicotine Content (VLNC) cigarettes (VLNC1)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Very Low Nicotine Content (VLNC) cigarettes (VLNC2)
Number of subjects: 136
Study: 26135349

Group type: EXPERIMENTAL
Intervention: Butter intake
Number of subjects: 47

Group type: COMPARATOR
Intervention: Olive oil intake
Number of subjects: 47

Group type: COMPARATOR
Intervention: Habitual diet (run-in period)
Number of subjects: 47
Study: 23443901

Group type: EXPERIMENTAL
Intervention: Interfascial bupivacaine administration
Number of subjects: 60

Group type: COMPARATOR
Intervention: Suprafascial bupivacaine administration
Number of subjects: 60
Study: 21314871

Group type: COMPARATOR
Intervention: Duloxetine treatment
Number of subjects: 5111

Group type: EXPERIMENTAL
Intervention: Duloxetine treatment for fibromyalgia and CLBP
Number of subjects: 5111

Group type: EXPERIMENTAL
Intervention: Duloxetine treatment for DPNP
Number of subjects: 5111
Study: 20108851

Group type: EXPERIMENTAL
Intervention: Scapular Mobilization (SM)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control
Number of subjects: 39
Study: 17824890

Group type: EXPERIMENTAL
Intervention: Early loading of mandibular implant overdentures delivered 1 week after surgery
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional mandibular prostheses converted to mandibular implant overdentures 3 months after surgery
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Prosthodontic maintenance of the mandibular implant overdentures in the first year
Number of subjects: 20
Study: 15888499

Group type: EXPERIMENTAL
Intervention: Direct Stenting (DS)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Pre-dilatation (PD)
Number of subjects: 202
Study: 11815428

Group type: EXPERIMENTAL
Intervention: Fosinopril 20 mg
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Fosinopril 40 mg
Number of subjects: 96

Group type: COMPARATOR
Intervention: Amlodipine 5 mg
Number of subjects: 96

Group type: COMPARATOR
Intervention: Amlodipine 10 mg
Number of subjects: 96

Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Fosinopril
Number of subjects: 96
Study: 10730079

Group type: EXPERIMENTAL
Intervention: Preoperative epidural morphine 2 mg at T 6‐7 and 2 mg at L 3‐4
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Continuous thoracic epidural infusion of 1% lidocaine (lidocaine group, n = 15)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Continuous thoracic epidural infusion of normal saline solution (control group, n = 15)
Number of subjects: 30
Study: 7854537

Group type: EXPERIMENTAL
Intervention: Carbidopa/levodopa
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Carbidopa/levodopa plus selegiline
Number of subjects: 11
Study: 1763311

Group type: EXPERIMENTAL
Intervention: hybrid composite P‐30
Number of subjects: 15

Group type: COMPARATOR
Intervention: dentine adhesive composite systems (5 different types)
Number of subjects: 15
Study: 7357821

Group type: EXPERIMENTAL
Intervention: Elemental diet supplements
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no elemental diet)
Number of subjects: 0
Study: 31268369

Group type: EXPERIMENTAL
Intervention: Tildrakizumab 100 mg
Number of subjects: 352
Study: 30576888

Group type: EXPERIMENTAL
Intervention: Sagittal plastinated slices (SPS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional anatomy teaching resources (dry bones and whole cadaveric feet)
Number of subjects: 0
Study: 28747220

Group type: EXPERIMENTAL
Intervention: HALS-CME (hand-assisted laparoscopic surgery with complete mesocolic excision, D3 lymphadenectomy, and total 'no-touch' isolation technique)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LAP-CME (laparoscopic surgery with complete mesocolic excision, D3 lymphadenectomy, and total 'no-touch' isolation technique)
Number of subjects: 0

Group type: COMPARATOR
Intervention: cLAP (conventional laparoscopic surgery with complete mesocolic excision and D3 lymphadenectomy)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Postoperative outcomes
Number of subjects: 0
Study: 25965082

Group type: EXPERIMENTAL
Intervention: Low-dose prophylactic corticosteroid (PCS) starting dose 15 mg/day of prednisolone for 6 weeks (PCS-On group)
Number of subjects: 295

Group type: COMPARATOR
Intervention: No prophylactic corticosteroid (PCS-Off group)
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Both groups (PCS-On and PCS-Off)
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Thyroid-stimulating antibody
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Clinical activity score (≥1 vs 0)
Number of subjects: 295
Study: 23937476

Group type: EXPERIMENTAL
Intervention: Sensory electrical stimulation (e-stim) at 75% of motor threshold
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Motor electrical stimulation (e-stim) at motor threshold
Number of subjects: 20
Study: 21279975

Group type: COMPARATOR
Intervention: Standard PDT (10‐minute 6 mg/mq2 verteporfin infusion; treatment at 15 min; 50 J/cm2; 83 s)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Bolus PDT (6 mg/mq2 verteporfin infusion bolus in 1 min; treatment at 5 min; 100 J/cm2; 166 s)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Bolus PDT
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard PDT
Number of subjects: 20
Study: 19104168

Group type: EXPERIMENTAL
Intervention: Laryngoscope group (rigid laryngoscope-assisted insertion)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional group (blind insertion)
Number of subjects: 80
Study: 17551418

Group type: EXPERIMENTAL
Intervention: Nutritional supplement
Number of subjects: 35
Study: 15110440

Group type: EXPERIMENTAL
Intervention: Computer-based training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Instructor-led training
Number of subjects: 0
Study: 11240080

Group type: EXPERIMENTAL
Intervention: Face‐to‐face healing for 30 min per week for 8 weeks
Number of subjects: 120

Group type: COMPARATOR
Intervention: Simulated face‐to‐face healing for 30 min per week for 8 weeks
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Distant healing for 30 min per week for 8 weeks
Number of subjects: 120

Group type: COMPARATOR
Intervention: No healing for 30 min per week for 8 weeks
Number of subjects: 120
Study: 10920971

Group type: EXPERIMENTAL
Intervention: Zudan
Number of subjects: 30

Group type: COMPARATOR
Intervention: Zofran
Number of subjects: 30
Study: 8083077

Group type: COMPARATOR
Intervention: Cohort 1: Three cycles of radiotherapy alone (48.6 Gy)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cohort 2: Three completed cycles of chemotherapy and radiotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cohort 3: Three completed cycles and a fourth radiotherapy course (64.8 Gy)
Number of subjects: 0
Study: 2634468

Group type: COMPARATOR
Intervention: Water-soluble contrast medium (WSCM)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Water-soluble contrast medium (WSCM) + oil-soluble contrast medium (OSCM)
Number of subjects: 109
Study: 1271224

Group type: EXPERIMENTAL
Intervention: Close interpersonal distance (confederate standing immediately adjacent)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Moderate interpersonal distance (one urinal removed)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No interpersonal distance (confederate absent)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Close interpersonal distance
Number of subjects: 60
Study: 31386937

Group type: EXPERIMENTAL
Intervention: High anticholinergic burden (ARS ≥ 2)
Number of subjects: 118750
Study: 27615555

Group type: EXPERIMENTAL
Intervention: Vosaroxin combined with cytarabine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cytarabine alone
Number of subjects: 0
Study: 26277524

Group type: EXPERIMENTAL
Intervention: HBO therapy at 0.175 MPa
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: HBO therapy at 0.2 MPa
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control group (no HBO therapy)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: HBO therapy at 0.175 MPa and 0.2 MPa
Number of subjects: 93
Study: 23607238

Group type: EXPERIMENTAL
Intervention: Autologous blood transfusion (n = 55)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Allogeneic blood transfusion (n = 57)
Number of subjects: 112
Study: 21501481

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy of lower intensity with CMF
Number of subjects: 327

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with CAF
Number of subjects: 327

Group type: EXPERIMENTAL
Intervention: Hormonal therapy alone following surgery and/or radiation therapy
Number of subjects: 327

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 327

Group type: EXPERIMENTAL
Intervention: Molecular subtypes correlation with recurrence risk
Number of subjects: 327
Study: 19452526

Group type: EXPERIMENTAL
Intervention: Intake of fresh meat
Number of subjects: 120852

Group type: EXPERIMENTAL
Intervention: Intake of processed meat
Number of subjects: 120852

Group type: EXPERIMENTAL
Intervention: Intake of fish
Number of subjects: 120852

Group type: EXPERIMENTAL
Intervention: Intake of eggs
Number of subjects: 120852

Group type: EXPERIMENTAL
Intervention: Dietary intake of total fat
Number of subjects: 120852

Group type: EXPERIMENTAL
Intervention: Different types of fat
Number of subjects: 120852
Study: 16822585

Group type: EXPERIMENTAL
Intervention: Pulmonary hypertension patients
Number of subjects: 9

Group type: COMPARATOR
Intervention: Controls (N=8)
Number of subjects: 9
Study: 14687052

Group type: EXPERIMENTAL
Intervention: Abdominal sacro‐colpopexy
Number of subjects: 82
Study: 11123197

Group type: EXPERIMENTAL
Intervention: 20% lipid (2 kcal/min) + vehicle
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 20% lipid + duodenal 0.75% benzocaine
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 20% lipid + jejunal 0.75% benzocaine
Number of subjects: 9

Group type: COMPARATOR
Intervention: Isotonic saline + vehicle
Number of subjects: 9
Study: 9429014

Group type: EXPERIMENTAL
Intervention: Swimmers
Number of subjects: 459

Group type: EXPERIMENTAL
Intervention: Male national standard swimmers (n = 38)
Number of subjects: 459

Group type: COMPARATOR
Intervention: Years of swimming training controlled
Number of subjects: 459

Group type: COMPARATOR
Intervention: Land based athletes and sedentary controls
Number of subjects: 459
Study: 8328375

Group type: EXPERIMENTAL
Intervention: Nisoldipine therapy
Number of subjects: 115
Study: 3087307

Group type: EXPERIMENTAL
Intervention: Cefotaxime sodium at a dosage of 12 g/day
Number of subjects: 187

Group type: COMPARATOR
Intervention: Nafcillin sodium and tobramycin sulfate
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Cefotaxime sodium
Number of subjects: 187
Study: 31994953

Group type: EXPERIMENTAL
Intervention: Prolonged minimal enteral nutrition (MEN)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Early feeding advancement
Number of subjects: 199
Study: 30120168

Group type: EXPERIMENTAL
Intervention: Minilaparotomy performed by trained Clinical Officers (COs)
Number of subjects: 1970

Group type: COMPARATOR
Intervention: Minilaparotomy performed by trained Assistant Medical Officers (AMOs)
Number of subjects: 1970
Study: 27189825

Group type: EXPERIMENTAL
Intervention: OPA-15406 1%
Number of subjects: 121

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 121
Study: 24087989

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH; nadroparin) for 1 week
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH; nadroparin)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Conventional treatment (Control group)
Number of subjects: 66
Study: 22439781

Group type: EXPERIMENTAL
Intervention: Tigecycline (TGC) 100 mg followed by 50 mg q 12 h
Number of subjects: 387

Group type: COMPARATOR
Intervention: Ceftriaxone plus Metronidazole (CTX/MET) 2 g qd plus 1-2 g daily
Number of subjects: 387

Group type: EXPERIMENTAL
Intervention: Tigecycline (TGC)
Number of subjects: 387

Group type: COMPARATOR
Intervention: Ceftriaxone plus Metronidazole (CTX/MET)
Number of subjects: 387
Study: 20733444

Group type: EXPERIMENTAL
Intervention: 20 international units oxytocin diluted with 26 mL saline
Number of subjects: 412

Group type: COMPARATOR
Intervention: 30 mL saline (placebo)
Number of subjects: 412
Study: 18054289

Group type: EXPERIMENTAL
Intervention: Pre-intervention period (two years prior to intervention)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Study arms of the Connecticut Collaboration for Falls Prevention
Number of subjects: 0
Study: 16983909

Group type: EXPERIMENTAL
Intervention: Integrated Chinese and Western medicine (ICWM) protocol
Number of subjects: 404

Group type: COMPARATOR
Intervention: Western medicine plus placebo
Number of subjects: 404
Study: 12534515

Group type: EXPERIMENTAL
Intervention: 585‐nm pulsed dye laser (PDL) treatment on one scar half
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control (no treatment on the other scar half)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 585‐nm pulsed dye laser (PDL) treatment
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 11
Study: 12521468

Group type: EXPERIMENTAL
Intervention: Pre-colposcopy group session led by a trained colposcopy nurse
Number of subjects: 147

Group type: COMPARATOR
Intervention: Conventional management
Number of subjects: 147
Study: 9599825

Group type: EXPERIMENTAL
Intervention: Pelvic Cradle
Number of subjects: 90

Group type: COMPARATOR
Intervention: Current stabilization practices
Number of subjects: 90

Group type: COMPARATOR
Intervention: Pron Pillo and current stabilization practices
Number of subjects: 90
Study: 7921756

Group type: EXPERIMENTAL
Intervention: Dysprosium‐165 Hydroxide Macroaggregate (165Dy)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Yttrium‐90 Silicate (90Y)
Number of subjects: 59
Study: 2971274

Group type: EXPERIMENTAL
Intervention: Preservative free ipratropium bromide nebuliser solution
Number of subjects: 30

Group type: COMPARATOR
Intervention: Atrovent nebuliser solution
Number of subjects: 30
Study: 31451362

Group type: EXPERIMENTAL
Intervention: Parental sex education program (practical booklet and booster session)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 153
Study: 31325152

Group type: EXPERIMENTAL
Intervention: MPT (melphalan, prednisolone, thalidomide)
Number of subjects: 103

Group type: COMPARATOR
Intervention: MP (melphalan, prednisolone)
Number of subjects: 103
Study: 28404008

Group type: EXPERIMENTAL
Intervention: Surgical treatment (resection)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Conservative management
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 109
Study: 26546405

Group type: EXPERIMENTAL
Intervention: Aripiprazole 15 mg orally disintegrating tablet (ODT) without water
Number of subjects: 39

Group type: COMPARATOR
Intervention: Conventional aripiprazole 15 mg standard tablet with 240 mL water
Number of subjects: 39
Study: 23501053

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-violent control task
Number of subjects: 0
Study: 21802823

Group type: EXPERIMENTAL
Intervention: ASA therapy suspended 7 days before tooth extraction (group S)
Number of subjects: 63

Group type: COMPARATOR
Intervention: ASA therapy unaltered (group NS)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: ASA therapy suspended (group S)
Number of subjects: 63
Study: 19381991

Group type: EXPERIMENTAL
Intervention: Unsaturated margarine
Number of subjects: 121

Group type: COMPARATOR
Intervention: Butter (saturated group)
Number of subjects: 121
Study: 16936457

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy combined with intravenous edaravone administration for 7 days
Number of subjects: 38

Group type: COMPARATOR
Intervention: Conventional treatment (Control group)
Number of subjects: 38
Study: 15502927

Group type: EXPERIMENTAL
Intervention: Oral insulin
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 11401940

Group type: EXPERIMENTAL
Intervention: Gemfibrozil 1200 mg/d
Number of subjects: 2531

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2531
Study: 11327443

Group type: EXPERIMENTAL
Intervention: High-dose didanosine
Number of subjects: 2411

Group type: EXPERIMENTAL
Intervention: Didanosine
Number of subjects: 2411

Group type: COMPARATOR
Intervention: Zidovudine
Number of subjects: 2411
Study: 8217757

Group type: EXPERIMENTAL
Intervention: Cyclosporin (5 mg/kg/day)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Cyclosporin
Number of subjects: 33
Study: 3104249

Group type: EXPERIMENTAL
Intervention: Radiation therapy plus Misonidazole (MISO) (400 mg/m2 daily 2 to 4 hours prior to radiation therapy)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Radiation therapy alone (4600 cGy pelvis plus 1000 cGy parametrial boost)
Number of subjects: 119
Study: 30375013

Group type: EXPERIMENTAL
Intervention: True acupressure
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sham acupressure
Number of subjects: 32
Study: 28641680

Group type: EXPERIMENTAL
Intervention: Integrated resistance and aerobic training (iRAT) during HDTBR
Number of subjects: 15

Group type: COMPARATOR
Intervention: No exercise during HDTBR (Control)
Number of subjects: 15
Study: 25923150

Group type: EXPERIMENTAL
Intervention: Intramuscular diclofenac 75 mg and sublingual methylcobalamin
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sublingual piroxicam 40 mg and intramuscular distilled water
Number of subjects: 100
Study: 24308190

Group type: EXPERIMENTAL
Intervention: Acupuncture intervention combined with hyperbaric oxygen therapy
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (hyperbaric oxygen therapy only)
Number of subjects: 62
Study: 21619382

Group type: EXPERIMENTAL
Intervention: Perindopril
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Valsartan
Number of subjects: 53

Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 53
Study: 19299519

Group type: EXPERIMENTAL
Intervention: Family-centered interventions
Number of subjects: 9
Study: 16797249

Group type: EXPERIMENTAL
Intervention: Onercept 10 mg
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Onercept 25 mg
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Onercept 35 mg
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Onercept 50 mg
Number of subjects: 207

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 207
Study: 12878450

Group type: EXPERIMENTAL
Intervention: Head cooling combined with minimal hypothermia (rectal temperature 36.5-36 degrees C) for 72 hours
Number of subjects: 21

Group type: COMPARATOR
Intervention: Standard therapy (Group 1a)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (Group 2)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Cooling group (Group 1b) after 36 hours
Number of subjects: 21
Study: 11127623

Group type: EXPERIMENTAL
Intervention: Psychological debriefing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 9583651

Group type: EXPERIMENTAL
Intervention: Cigarette brand switching
Number of subjects: 11966

Group type: EXPERIMENTAL
Intervention: Company switching
Number of subjects: 11966

Group type: EXPERIMENTAL
Intervention: Top-selling premium brands (Marlboro, Camel, Newport)
Number of subjects: 11966

Group type: EXPERIMENTAL
Intervention: Actual unit sales for Marlboro and Camel
Number of subjects: 11966

Group type: EXPERIMENTAL
Intervention: Premium brand cigarettes
Number of subjects: 11966
Study: 8416666

Group type: EXPERIMENTAL
Intervention: 6 g fish oil/d (50% n‐3 fatty acids)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 12 g fish oil/d (50% n‐3 fatty acids)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Olive oil placebo
Number of subjects: 18